Bravecto
216 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
216
Total Reports
21
Deaths Reported
970.0%
Death Rate
Active Ingredients
Bravecto
Administration Routes
UnknownOralTopicalSubcutaneous
Species Affected
Dog 192
Cat 24
Most Affected Breeds
Retriever - Labrador 27
Domestic Shorthair 17
Retriever - Golden 16
Crossbred Canine/dog 12
Terrier - Bull - American Pit 12
Boxer (German Boxer) 9
Bulldog - French 9
Shepherd Dog - German 8
Terrier (unspecified) 6
Shepherd Dog - Australian 5
Most Reported Reactions
Vomiting 27
Seizure NOS 24
Lack of efficacy - NOS 23
Diarrhoea 15
Ataxia 15
Not eating 12
Elevated serum alkaline phosphatase (ALP) 12
Intentional misuse 12
Lethargy (see also Central nervous system depression in Neurological) 11
Death 10
Lethargy (see also Central nervous system depression in 'Neurological') 10
Death by euthanasia 10
Outcome Breakdown
Ongoing
141 (65.3%)
Recovered/Normal
33 (15.3%)
Outcome Unknown
21 (9.7%)
Died
11 (5.1%)
Euthanized
10 (4.6%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.